Altered Brain Glucose Metabolism in COVID-19 Disease: an Activation Likelihood Estimation Meta-analysis of PET Studies

Overview

Journal Brain Imaging Behav

Publisher Springer

Date 2025 Jan 24

PMID 39853627

Authors

Dongju Kang

Hyunji Jung

Kyoungjune Pak

Affiliations

Soon will be listed here.

Abstract

COVID-19 disease, caused by the SARS-CoV-2 virus, has significantly altered modern society and lifestyles. We investigated its impact on brain glucose metabolism by meta-analyzing existing studies that utilized 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) scans of the brain. We conducted a systematic search of MEDLINE and EMBASE databases from inception to August 2024 for English-language publications using the keywords "positron emission tomography", and "COVID-19". We included original research articles that reported changes in brain glucose metabolism following COVID-19 disease. ALE values from these studies were aggregated and tested against a null hypothesis that anticipated a random distribution of ALE values, which proved to be significantly higher than chance. We identified nine papers that met our inclusion criteria. Significant increases in brain glucose metabolism were noted in the left anterior cingulate gyrus, right thalamus, and brainstem. In children with COVID-19 disease, decreased glucose metabolism was observed in the right and left cerebellum, left amygdala/hippocampus, left anterior cingulate gyrus, and right amygdala. In adults with COVID-19 disease, decreased metabolism was seen in the right temporal lobe, brainstem (acute phase), left occipital lobe, left and right temporal lobe (chronic phase). In conclusion, COVID-19 disease impacts brain glucose metabolism, typically manifesting as areas of decreased metabolism in F-FDG PET scans, though increases are also observed. These changes in metabolism vary with the patient's age and the time elapsed between the diagnosis of COVID-19 disease and the PET scan.

References

ABraham A, Mathai K . The effect of right temporal lobe lesions on matching of smells. Neuropsychologia. 1983; 21(3):277-81. DOI: 10.1016/0028-3932(83)90045-3. View

Ahmad I, Rathore F . Neurological manifestations and complications of COVID-19: A literature review. J Clin Neurosci. 2020; 77:8-12. PMC: 7200361. DOI: 10.1016/j.jocn.2020.05.017. View

Binder J, Frost J, Hammeke T, Bellgowan P, Springer J, Kaufman J . Human temporal lobe activation by speech and nonspeech sounds. Cereb Cortex. 2000; 10(5):512-28. DOI: 10.1093/cercor/10.5.512. View

Boparai M, Musheyev B, Hou W, Mehler M, Duong T . Brain MRI findings in severe COVID-19 patients: a meta-analysis. Front Neurol. 2023; 14:1258352. PMC: 10602808. DOI: 10.3389/fneur.2023.1258352. View

Bouter C, Henniges P, Franke T, Irwin C, Sahlmann C, Sichler M . F-FDG-PET Detects Drastic Changes in Brain Metabolism in the Tg4-42 Model of Alzheimer's Disease. Front Aging Neurosci. 2019; 10:425. PMC: 6333025. DOI: 10.3389/fnagi.2018.00425. View

Callan D, Kawato M, Parsons L, Turner R . Speech and song: the role of the cerebellum. Cerebellum. 2007; 6(4):321-7. DOI: 10.1080/14734220601187733. View

Casabianca M, Caula C, Titomanlio L, Lenglart L . Neurological consequences of SARS-CoV-2 infections in the pediatric population. Front Pediatr. 2023; 11:1123348. PMC: 9973732. DOI: 10.3389/fped.2023.1123348. View

Cho S, White N, Premraj L, Battaglini D, Fanning J, Suen J . Neurological manifestations of COVID-19 in adults and children. Brain. 2022; 146(4):1648-1661. PMC: 9494397. DOI: 10.1093/brain/awac332. View

Cocciolillo F, Di Giuda D, Morello R, De Rose C, Valentini P, Buonsenso D . Orbito-Frontal Cortex Hypometabolism in Children With Post-COVID Condition (Long COVID): A Preliminary Experience. Pediatr Infect Dis J. 2022; 41(8):663-665. PMC: 9281418. DOI: 10.1097/INF.0000000000003578. View

10.

Debs P, Khalili N, Solnes L, Al-Zaghal A, Sair H, Yedavalli V . Post-COVID-19 Brain [F] FDG-PET Findings: A Retrospective Single-Center Study in the United States. AJNR Am J Neuroradiol. 2023; 44(5):517-522. PMC: 10171380. DOI: 10.3174/ajnr.A7863. View

11.

Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P . SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022; 604(7907):697-707. PMC: 9046077. DOI: 10.1038/s41586-022-04569-5. View

12.

Eickhoff S, Laird A, Grefkes C, Wang L, Zilles K, Fox P . Coordinate-based activation likelihood estimation meta-analysis of neuroimaging data: a random-effects approach based on empirical estimates of spatial uncertainty. Hum Brain Mapp. 2009; 30(9):2907-26. PMC: 2872071. DOI: 10.1002/hbm.20718. View

13.

Eickhoff S, Bzdok D, Laird A, Kurth F, Fox P . Activation likelihood estimation meta-analysis revisited. Neuroimage. 2011; 59(3):2349-61. PMC: 3254820. DOI: 10.1016/j.neuroimage.2011.09.017. View

14.

Favas T, Dev P, Chaurasia R, Chakravarty K, Mishra R, Joshi D . Neurological manifestations of COVID-19: a systematic review and meta-analysis of proportions. Neurol Sci. 2020; 41(12):3437-3470. PMC: 7577367. DOI: 10.1007/s10072-020-04801-y. View

15.

Freeman C, Masur J, Hassankhani A, Wolf R, Levine J, Mohan S . Coronavirus Disease (COVID-19)-Related Disseminated Leukoencephalopathy: A Retrospective Study of Findings on Brain MRI. AJR Am J Roentgenol. 2020; 216(4):1046-1047. PMC: 9985006. DOI: 10.2214/AJR.20.24364. View

16.

GODDARD G . FUNCTIONS OF THE AMYGDALA. Psychol Bull. 1964; 62:89-109. DOI: 10.1037/h0044853. View

17.

Goehringer F, Bruyere A, Doyen M, Bevilacqua S, Charmillon A, Heyer S . Brain F-FDG PET imaging in outpatients with post-COVID-19 conditions: findings and associations with clinical characteristics. Eur J Nucl Med Mol Imaging. 2022; 50(4):1084-1089. PMC: 9628394. DOI: 10.1007/s00259-022-06013-2. View

18.

Guedj E, Campion J, Dudouet P, Kaphan E, Bregeon F, Tissot-Dupont H . F-FDG brain PET hypometabolism in patients with long COVID. Eur J Nucl Med Mol Imaging. 2021; 48(9):2823-2833. PMC: 7837643. DOI: 10.1007/s00259-021-05215-4. View

19.

Haug N, Geyrhofer L, Londei A, Dervic E, Desvars-Larrive A, Loreto V . Ranking the effectiveness of worldwide COVID-19 government interventions. Nat Hum Behav. 2020; 4(12):1303-1312. DOI: 10.1038/s41562-020-01009-0. View

20.

Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C . Neurologic Features in Severe SARS-CoV-2 Infection. N Engl J Med. 2020; 382(23):2268-2270. PMC: 7179967. DOI: 10.1056/NEJMc2008597. View